01/07/2022 | Press release | Distributed by Public on 01/07/2022 08:29
Please select the service you want to use:
Smartlinks | BioCryst Pharmaceuticals Inc. | News | Health | Science | Research | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Public Companies | Pharmaceutical Companies | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Bolsa Institucional de Valores (BIVA)
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact